A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

NCT ID: NCT01686620


Title
A Randomized, Parallel Group Trial Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes Using Basal-bolus Insulin Injection Therapy
Purpose
The purpose of this study is to evaluate the safety and efficacy of BIOD-123 compared to insulin lispro (Humalog®) when used as part of a basal-bolus regimen in patients with type 1 diabetes.
Details
Conditions
Type 1 Diabetes Mellitus
Keywords
Mealtime insulin, Ultra-rapid acting insulin, Prandial insulin
Source
Biodel
Sponsors
Biodel
Status
Completed
Acronym
Last Updated
21 Jul 2015
URL
Official Link
Locations
United States